Pemetrexed, oxaliplatin and bevacizumab as first-line treatment in patients with stage IV non-small cell lung cancer-Reference-Cited by-同舟云学术

Pemetrexed, oxaliplatin and bevacizumab as first-line treatment in patients with stage IV non-small cell lung cancer

Published:2012-07 Issue:1 Volume:77 Page:104-109
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Mir Olivier,Boudou-Rouquette Pascaline,Giroux Julie,Chapron Jeanne,Alexandre Jérôme,Gibault Laure,Ropert Stanislas,Coriat Romain,Durand Jean-Philippe,Burgel Pierre-Régis,Dusser Daniel,Goldwasser François

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference37 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;D’Addario;Ann Oncol,2010

3. Pemetrexed: a review of its use in the management of advanced non-squamous non-small cell lung cancer;Baldwin;Drugs,2009

4. Paclitaxel–carboplatin alone or with bevacizumab for non-small-cell lung cancer;Sandler;N Engl J Med,2006

5. Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study;Crino;Lancet Oncol,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Efficacy of Drug-eluting Bead Transarterial Chemoembolization Loaded With Oxaliplatin for the Treatment of Stage III-IV Non-small-cell Lung Cancer;Academic Radiology;2022-11

2. Progress in Research on Tumor Metastasis Inhibitors;Current Medicinal Chemistry;2020-10-11

3. Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-AS;PLOS ONE;2017-02-13

4. Efficacy of cisplatin/pemetrexed with bevacizumab to treat advanced lung adenocarcinoma with different drive genes: case report and literature review;OncoTargets and Therapy;2016-07

5. Pemetrexed With Platinum Combination as a Backbone for Targeted Therapy in Non–Small-Cell Lung Cancer;Clinical Lung Cancer;2016-01